
1. antimicrob agents chemother. 2016 jul 22;60(8):4886-95. doi:
10.1128/aac.00820-16. print 2016 aug.

antimalarial benzoxaboroles target plasmodium falciparum leucyl-trna synthetase.

sonoiki e(1), palencia a(2), guo d(3), ahyong v(4), dong c(5), li x(5), hernandez
vs(5), zhang yk(5), choi w(5), gut j(3), legac j(3), cooper r(6), alley mr(5),
freund yr(5), derisi j(4), cusack s(2), rosenthal pj(7).

author information: 
(1)department medicine, university california, san francisco, california,
usa division infectious diseases immunology, school public health,
university california, berkeley, california, usa.
(2)european molecular biology laboratory, grenoble outstation université
joseph fourier, centre national de la recherche scientifique embl unit of
virus host-cell interactions, grenoble, france.
(3)department medicine, university california, san francisco, california,
usa.
(4)howard hughes medical institute department biochemistry and
biophysics, university california, san francisco, california, usa.
(5)anacor pharmaceuticals, inc., palo alto, california, usa.
(6)department natural sciences mathematics, dominican university of
california, san rafael, california, usa.
(7)department medicine, university california, san francisco, california,
usa philip.rosenthal@ucsf.edu.

there need new antimalarials, ideally novel mechanisms action.
benzoxaboroles shown active bacteria, fungi, and
trypanosomes. therefore, investigated antimalarial activity mechanism 
of action 3-aminomethyl benzoxaboroles plasmodium falciparum two
3-aminomethyl compounds, an6426 an8432, demonstrated good potency against
cultured multidrug-resistant (w2 strain) p. falciparum (50% inhibitory
concentration [ic50] 310 nm 490 nm, respectively) efficacy against
murine plasmodium berghei infection administered orally daily 4
days (90% effective dose [ed90], 7.4 16.2 mg/kg body weight,
respectively). characterize mechanisms action, selected parasites with
decreased drug sensitivity culturing stepwise increases concentration 
of an6426. resistant clones characterized whole-genome sequencing. three 
generations resistant parasites polymorphisms predicted editing
domain gene encoding p. falciparum leucyl-trna synthetase (leurs;
pf3d7_0622800) another gene (pf3d7_1218100), encodes protein of
unknown function. solution structure p. falciparum leurs editing
domain suggested key roles mutated residues leurs editing. short
incubations an6426 an8432, unlike artemisinin, caused dose-dependent
inhibition [(14)c]leucine incorporation cultured wild-type, not
resistant, parasites. growth resistant, wild-type, parasites was
impaired presence unnatural amino acid norvaline, consistent a
loss leurs editing activity resistant parasites. summary, the
benzoxaboroles an6426 an8432 offer effective antimalarial activity act,
at least part, novel target, editing domain p. falciparum
leurs.

copyright © 2016, american society microbiology. rights reserved.

doi: 10.1128/aac.00820-16 
pmcid: pmc4958189
pmid: 27270277  [indexed medline]

